Cargando…

Toll-Like Receptors in Secondary Obstructive Cholangiopathy

Secondary obstructive cholangiopathy is characterized by intra- or extrahepatic bile tract obstruction. Liver inflammation and structural alterations develop due to progressive bile stagnation. Most frequent etiologies are biliary atresia in children, and hepatolithiasis, postcholecystectomy bile du...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miranda-Díaz, A. G., Alonso-Martínez, H., Hernández-Ojeda, J., Arias-Carvajal, O., Rodríguez-Carrizalez, A. D., Román-Pintos, L. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205723/ https://www.ncbi.nlm.nih.gov/pubmed/22114589 http://dx.doi.org/10.1155/2011/265093

Ejemplares similares

Toll-Like Receptor-1 and Receptor-2 and Beta-Defensin in Postcholecystectomy Bile Duct Injury
por: Miranda-Díaz, Alejandra Guillermina, et al.
Publicado: (2015)

Cholangiopathy as part of post-COVID syndrome
por: Rojas, Manuel, et al.
Publicado: (2021)

Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study
por: Hernández-Ojeda, Jaime, et al.
Publicado: (2014)

Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Villegas-Rivera, Geannyne, et al.
Publicado: (2015)

Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function
por: Román-Pintos, Luis Miguel, et al.
Publicado: (2016)

IgG4 Cholangiopathy
por: Zen, Yoh, et al.
Publicado: (2012)

Tutorial Review for Understanding of Cholangiopathy
por: Nakanuma, Yasuni
Publicado: (2012)

Cholangiopathy: Genetics, Mechanism, and Pathology
por: Nakanuma, Yasuni, et al.
Publicado: (2012)

The Crucial Role of Cholangiocytes in Cholangiopathies
por: Park, Seon Mee
Publicado: (2012)

Cholangiopathy with Respect to Biliary Innate Immunity
por: Harada, Kenichi, et al.
Publicado: (2012)

Cholangiopathies – Towards a molecular understanding
por: Tam, Paul K.H., et al.
Publicado: (2018)

Non-neoplastic cholangiopathies: an algorithmic approach
por: Zacarias, Marina Silva, et al.
Publicado: (2020)

A rare case of eosinophilic cholangiopathy
por: Li, Wenya, et al.
Publicado: (2020)

New Therapeutic Targets in Autoimmune Cholangiopathies
por: Gerussi, Alessio, et al.
Publicado: (2020)

Ketamine-induced cholangiopathy in ARDS patients
por: de Tymowski, Christian, et al.
Publicado: (2021)

Histological Changes in Portal Cavernoma Cholangiopathy
por: Rastogi, Archana, et al.
Publicado: (2023)

Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered
por: Deltenre, Pierre, et al.
Publicado: (2021)

Expression of Toll-Like Receptors in the Animal Model of Bladder Outlet Obstruction
por: Niemczyk, Grzegorz, et al.
Publicado: (2020)

Reply to: “Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered”
por: Mallet, Vincent
Publicado: (2021)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment
por: Lorenzo Pisarello, Maria Jose, et al.
Publicado: (2015)

Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies
por: Giordano, Debora Maria, et al.
Publicado: (2018)

Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies
por: Cannito, Stefania, et al.
Publicado: (2018)

Portal Cavernoma Cholangiopathy in Children and the Management Dilemmas
por: Sarma, Moinak Sen, et al.
Publicado: (2020)

Persistent Ketamine-Induced Cholangiopathy: An Approach to Management
por: Nyirenda, Tiwonge J, et al.
Publicado: (2020)

Post-COVID cholangiopathy: A narrative review
por: Caballero-Alvarado, José, et al.
Publicado: (2023)

Billiary casts in post-COVID-19 cholangiopathy()
por: Soldera, Jonathan, et al.
Publicado: (2023)

Post-COVID cholangiopathy: A narrative review
por: Caballero-Alvarado, José, et al.
Publicado: (2023)

Billiary casts in post-COVID-19 cholangiopathy()
por: Soldera, Jonathan, et al.
Publicado: (2023)

Post-COVID-19 cholangiopathy: Systematic review
por: Rasheed, Mazen Abdalla, et al.
Publicado: (2023)

The effect of ubiquinone and combined antioxidant therapy on oxidative stress markers in non-proliferative diabetic retinopathy: A phase IIa, randomized, double-blind, and placebo-controlled study
por: Rodríguez-Carrizalez, Adolfo Daniel, et al.
Publicado: (2015)

The antioxidant effect of ubiquinone and combined therapy on mitochondrial function in blood cells in non-proliferative diabetic retinopathy: A randomized, double-blind, phase IIa, placebo-controlled study
por: Rodríguez-Carrizalez, Adolfo Daniel, et al.
Publicado: (2016)

Critical Illness Cholangiopathy in COVID-19 Long-haulers
por: Saleem, Nasir, et al.
Publicado: (2022)

CRITICAL ILLNESS CHOLANGIOPATHY IN COVID-19 LONG-HAULERS
por: Saleem, Nasir, et al.
Publicado: (2022)

Effect of statins on oxidative DNA damage in diabetic polyneuropathy
por: Carrillo-Ibarra, Sandra, et al.
Publicado: (2018)

Toll-Like Receptors, Inflammation, and Calcific Aortic Valve Disease
por: García-Rodríguez, Carmen, et al.
Publicado: (2018)

Unraveling the Role of Toll-like Receptors in the Immunopathogenesis of Selected Primary and Secondary Immunodeficiencies
por: Mertowska, Paulina, et al.
Publicado: (2023)

Toll-Like Receptors in Atherosclerosis
por: Falck-Hansen, Mika, et al.
Publicado: (2013)

Toll-Like Receptors in Angiogenesis
por: Grote, Karsten, et al.
Publicado: (2011)

Toll-like Receptors and Thrombopoiesis
por: Tang, Xiaoqin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7n0jg931eii4fdcl916vbkqfrp